This Article Full Text Full Text (PDF) All Versions of this Article: 149/6/3077    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Reed-Tsur, M. D. Articles by Carrasco, N. Search for Related Content PubMed PubMed Citation Articles by Reed-Tsur, M. D. Articles by Carrasco, N.

Molecular Characterization of V59E NIS, a Na⁺/I^– Symporter Mutant that Causes Congenital I^– Transport Defect

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

Address all correspondence and requests for reprints to: Nancy Carrasco, Albert Einstein College of Medicine, Department of Molecular Pharmacology, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: carrasco{at}aecom.yu.edu.

I^– is actively transported into thyrocytes via the Na⁺/I^– symporter (NIS), a key glycoprotein located on the basolateral plasma membrane. The cDNA encoding rat NIS was identified in our laboratory, where an extensive structure/function characterization of NIS is being conducted. Several NIS mutants have been identified as causes of congenital I^– transport defect (ITD), including V59E NIS. ITD is characterized by low thyroid I^– uptake, low saliva/plasma I^– ratio, hypothyroidism, and goiter and may cause mental retardation if untreated. Studies of other ITD-causing NIS mutants have revealed valuable information regarding NIS structure/function. V59E NIS was reported to exhibit as much as 30% of the activity of wild-type NIS. However, this observation was at variance with the patients’ phenotype of total lack of activity. We have thoroughly characterized V59E NIS and studied several amino acid substitutions at position 59. We demonstrated that, in contrast to the previous report, V59E NIS is inactive, although it is properly targeted to the plasma membrane. Glu and all other charged amino acids or Pro at position 59 also yielded nonfunctional NIS proteins. However, I^– uptake was rescued to different degrees by the other substitutions. Although the K_m values for Na⁺ and I^– were not altered in these active mutants, we found that the structural requirement for NIS function at position 59 is a neutral, helix-promoting amino acid. This result suggests that the region that contains V59 may be involved in intramembrane helix-helix interactions during the transport cycle without being in direct contact with the substrates.